Company profile
Ticker
AVBP
Exchange
Employees
Incorporated
Location
Fiscal year end
Sector
Industry (SIC)
SEC CIK
AVBP stock data
Latest filings (excl ownership)
8-K
ArriVent Announces a Multi-Target ADC Collaboration with Alphamab
5 Jun 24
8-K
ArriVent Appoints John Hohneker, M.D., to its Board of Directors
16 May 24
10-Q
2024 Q1
Quarterly report
8 May 24
8-K
ArriVent BioPharma Reports First Quarter 2024 Financial Results
8 May 24
8-K
ArriVent Appoints Kristine Peterson to its Board of Directors
22 Apr 24
10-K
2023 FY
Annual report
28 Mar 24
8-K
ArriVent Biopharma Reports Full Year 2023 Financial Results
28 Mar 24
S-8
Registration of securities for employees
2 Feb 24
8-K
Amendments to Articles of Incorporation or Bylaws
30 Jan 24
424B4
Prospectus supplement with pricing info
26 Jan 24
Latest ownership filings
4
John Hohneker
20 May 24
3
John Hohneker
20 May 24
4
Kristine Peterson
23 Apr 24
3
Kristine Peterson
23 Apr 24
SC 13G
LAV Fund VI, L.P.
13 Feb 24
SC 13D
ORBIMED ADVISORS LLC
5 Feb 24
4
Change in insider ownership
1 Feb 24
4
Change in insider ownership
31 Jan 24
4
CARL L GORDON
31 Jan 24
4
JAMES HEALY
31 Jan 24
Financial summary
Quarter (USD) | Mar 24 | Dec 23 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Annual (USD) | Dec 23 | |
---|---|---|
Revenue | ||
Cost of revenue | ||
Operating income | ||
Operating margin | ||
Net income | ||
Net profit margin | ||
Cash on hand | ||
Change in cash | ||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | |||
---|---|---|---|---|---|---|
Cash on hand (at last report) | 317.39 mm | 317.39 mm | ||||
Cash burn (monthly) | 6.89 mm | 6.21 mm | ||||
Cash used (since last report) | 19.78 mm | 17.82 mm | ||||
Cash remaining | 297.61 mm | 299.57 mm | ||||
Runway (months of cash) | 43.2 | 48.2 |
Institutional ownership, Q4 2023
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 May 24 | John Hohneker | Stock Option Common Stock | Grant | Acquire A | No | No | 20.15 | 29,550 | 595.43 k | 29,550 |
22 Apr 24 | Kristine Peterson | Stock Option Common Stock | Grant | Acquire A | No | No | 15.9 | 28,587 | 454.53 k | 28,587 |
30 Jan 24 | Orbimed Advisors | Common Stock | Buy | Acquire P | Yes | No | 18 | 222,222 | 4.00 mm | 1,513,664 |
30 Jan 24 | Orbimed Advisors | Common Stock | Buy | Acquire P | Yes | No | 18 | 222,222 | 4.00 mm | 1,513,664 |
30 Jan 24 | Orbimed Advisors | Common Stock | Conversion | Acquire C | Yes | No | 0 | 469,615 | 0.00 | 1,291,442 |
30 Jan 24 | Orbimed Advisors | Common Stock | Conversion | Acquire C | Yes | No | 0 | 469,615 | 0.00 | 1,291,442 |
30 Jan 24 | Orbimed Advisors | Common Stock | Conversion | Acquire C | Yes | No | 0 | 821,827 | 0.00 | 821,827 |
30 Jan 24 | Orbimed Advisors | Common Stock | Conversion | Acquire C | Yes | No | 0 | 821,827 | 0.00 | 821,827 |
30 Jan 24 | Orbimed Advisors | Series B Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 469,615 | 0.00 | 0 |
30 Jan 24 | Orbimed Advisors | Series B Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 469,615 | 0.00 | 0 |
News
HC Wainwright & Co. Reiterates Buy on ArriVent BioPharma, Maintains $25 Price Target
6 Jun 24
HC Wainwright & Co. Reiterates Buy on ArriVent BioPharma, Maintains $25 Price Target
9 May 24
ArriVent BioPharma Q1 EPS $(0.70) Beats $(1.05) Estimate
8 May 24
HC Wainwright & Co. Initiates Coverage On ArriVent BioPharma with Buy Rating, Announces Price Target of $25
30 Apr 24
ProfoundBio Discovers The Joys Of Having A Wealthy Owner
8 Apr 24